Alys Havard

2.8k total citations
87 papers, 2.0k citations indexed

About

Alys Havard is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Alys Havard has authored 87 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Public Health, Environmental and Occupational Health, 31 papers in Epidemiology and 29 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Alys Havard's work include Substance Abuse Treatment and Outcomes (20 papers), Prenatal Substance Exposure Effects (19 papers) and Opioid Use Disorder Treatment (16 papers). Alys Havard is often cited by papers focused on Substance Abuse Treatment and Outcomes (20 papers), Prenatal Substance Exposure Effects (19 papers) and Opioid Use Disorder Treatment (16 papers). Alys Havard collaborates with scholars based in Australia, Iceland and United Kingdom. Alys Havard's co-authors include Maree Teesson, Shane Darke, Joanne Ross, Anthony Shakeshaft, Rob Sanson‐Fisher, Katherine L. Mills, Anna Williamson, Louisa Jorm, Duong Thuy Tran and Deborah Randall and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Alys Havard

80 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alys Havard Australia	24	887	656	475	347	240	87	2.0k
Joe Barry Ireland	16	565 0.6×	490 0.7×	501 1.1×	253 0.7×	255 1.1×	45	1.7k
Ed Day United Kingdom	28	1.1k 1.3×	844 1.3×	627 1.3×	283 0.8×	326 1.4×	139	2.6k
Nigel Mathers United Kingdom	27	370 0.4×	924 1.4×	704 1.5×	205 0.6×	352 1.5×	83	2.5k
Alai Tan United States	26	390 0.4×	453 0.7×	946 2.0×	206 0.6×	421 1.8×	135	2.7k
Gerald Cochran United States	22	577 0.7×	1.1k 1.7×	291 0.6×	323 0.9×	110 0.5×	116	1.6k
Alyson B. Goodman United States	25	262 0.3×	759 1.2×	480 1.0×	417 1.2×	533 2.2×	64	3.1k
Sandra S. Albrecht United States	21	481 0.5×	475 0.7×	406 0.9×	178 0.5×	240 1.0×	56	2.4k
Karli Kondo United States	21	364 0.4×	274 0.4×	625 1.3×	169 0.5×	350 1.5×	50	2.4k
Gail D’Eramo Melkus United States	33	529 0.6×	569 0.9×	1.1k 2.3×	216 0.6×	395 1.6×	125	3.2k
Arthur Robin Williams United States	22	1.1k 1.2×	1.2k 1.8×	296 0.6×	400 1.2×	127 0.5×	70	2.0k

Countries citing papers authored by Alys Havard

Since Specialization

Citations

This map shows the geographic impact of Alys Havard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alys Havard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alys Havard more than expected).

Fields of papers citing papers by Alys Havard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alys Havard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alys Havard. The network helps show where Alys Havard may publish in the future.

Co-authorship network of co-authors of Alys Havard

This figure shows the co-authorship network connecting the top 25 collaborators of Alys Havard. A scholar is included among the top collaborators of Alys Havard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alys Havard. Alys Havard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Jialing, Claire T. Deakin, Juliana de Oliveira Costa, et al.. (2025). Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based study. Diabetes Research and Clinical Practice. 224. 112242–112242.

Powell, Madeleine, Rhiannon Pilkington, Mark Hanly, et al.. (2025). Prevalence of maternal substance use problems during pregnancy and the first 2 years of life: a whole-population birth cohort of 970 470 Australian children born 2008–2017. Journal of Epidemiology & Community Health. 79(8). 614–624. 1 indexed citations

Cesta, Carolyn E., Vidar Hjellvik, Sinna Pilgaard Ulrichsen, et al.. (2024). Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study. EClinicalMedicine. 70. 102531–102531. 5 indexed citations

Costa, Juliana de Oliveira, Jialing Lin, Jerry R. Greenfield, et al.. (2024). Geographic variation in sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia. Diabetes Obesity and Metabolism. 26(7). 2787–2795. 2 indexed citations

Zoëga, Helga, Michael O. Falster, M. Gillies, et al.. (2024). The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia. Pharmacoepidemiology and Drug Safety. 33(8). e5887–e5887. 1 indexed citations

Chidwick, Kendal, Chrianna Bharat, Alys Havard, et al.. (2024). Trends in prescription opioid analgesic use in Australia from 2015 to 2022. International Journal of Drug Policy. 135. 104666–104666. 1 indexed citations

Venetis, Christos, Stephanie Choi, Louisa Jorm, et al.. (2023). Risk for Congenital Anomalies in Children Conceived With Medically Assisted Fertility Treatment. Annals of Internal Medicine. 176(10). 1308–1320. 6 indexed citations

Varney, Bianca, Helga Zoëga, M. Gillies, et al.. (2023). Prevalence and Persistence of Prescription Opioid Use Following Hospital Discharge After Childbirth: An Australian Population-Based Cohort Study. Anesthesia & Analgesia. 138(5). 970–979.

Choi, Stephanie, Christos Venetis, William J. Ledger, et al.. (2022). Population-wide contribution of medically assisted reproductive technologies to overall births in Australia: temporal trends and parental characteristics. Human Reproduction. 37(5). 1047–1058. 22 indexed citations

10.

Havard, Alys, et al.. (2022). Tobacco use during pregnancy. Addiction. 117(6). 1801–1810. 21 indexed citations

11.

Havard, Alys, Mark Hanly, Kathleen Falster, et al.. (2022). Children's Relative Age and Medicine Treatment for Attention-Deficit/Hyperactivity Disorder Across Australian Jurisdictions with Different School Enrolment Policies. Journal of Child and Adolescent Psychopharmacology. 32(6). 349–357. 1 indexed citations

12.

Choi, Stephanie, Duong Thuy Tran, Anna Kemp, et al.. (2021). The Comparative Effectiveness of Varenicline and Nicotine Patches for Smoking Abstinence During Pregnancy: Evidence From a Population-based Cohort Study. Nicotine & Tobacco Research. 23(10). 1664–1672. 7 indexed citations

13.

Costa, Juliana de Oliveira, Frank Beard, David Alejandro González‐Chica, et al.. (2021). Cumulative annual coverage of meningococcal B vaccination in Australian general practice for three at-risk groups, 2014 to 2019. Human Vaccines & Immunotherapeutics. 17(10). 3692–3701. 4 indexed citations

14.

Chambers, Georgina, Stephanie Choi, Christos Venetis, et al.. (2021). A bespoke data linkage of an IVF clinical quality registry to population health datasets; methods and performance. International Journal for Population Data Science. 6(1). 1679–1679. 3 indexed citations

15.

Cohen, Jacqueline M., Carolyn E. Cesta, Kari Furu, et al.. (2020). Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006‐2016: A study in the five Nordic countries, United States, and Australia. Pharmacoepidemiology and Drug Safety. 29(8). 913–922. 36 indexed citations

16.

Kelty, Erin, et al.. (2019). Maternal and Neonatal Health Outcomes Associated with the Use of Gliclazide and Metformin for the Treatment of Diabetes in Pregnancy: A Record Linkage Study. Diabetes Technology & Therapeutics. 22(2). 96–102. 7 indexed citations

17.

Ford, Elizabeth, Andy Boyd, Juliana Bowles, et al.. (2019). Our data, our society, our health: A vision for inclusive and transparent health data science in the United Kingdom and beyond. Learning Health Systems. 3(3). e10191–e10191. 39 indexed citations

18.

Havard, Alys, Anthony Shakeshaft, & Katherine M. Conigrave. (2012). Prevalence and characteristics of patients with risky alcohol consumption presenting to emergency departments in rural Australia. Emergency Medicine Australasia. 24(3). 266–276. 14 indexed citations

19.

Darke, Shane, Katherine L. Mills, Maree Teesson, et al.. (2009). Patterns of major depression and drug-related problems amongst heroin users across 36 months. Psychiatry Research. 166(1). 7–14. 57 indexed citations

20.

Havard, Alys, Maree Teesson, Shane Darke, & Joanne Ross. (2006). Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment. 30(4). 355–362. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact